Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.0K
Overview
45.0K
Symbiosis00:58

Symbiosis

29.4K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
29.4K
Cancer Vaccines01:30

Cancer Vaccines

460
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
460
Diversity of Protists II01:27

Diversity of Protists II

77
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
77
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

99
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Membrane-Anchored and Sequence-Oriented Antiviral Activity of Fusion-Inhibitory Lipopeptides Derived from the SARS-CoV-2 Spike Glycoprotein S2 Subunit.

Viruses·2026
Same author

Detection of Diagnostic Antibodies in Immune-Mediated Diseases: A Focus on Antigens and Technologies.

Chembiochem : a European journal of chemical biology·2026
Same author

Structure-Guided Design of Temporin-Derived Peptides Reveals Potent Dual-Mechanism Inhibitors of SARS-CoV-2.

Journal of medicinal chemistry·2026
Same author

Breastfeeding in a Polluted World: Perspective on the Properties of Breast Milk and the Need for Protection.

Journal of clinical medicine·2025
Same author

CAMKK1 in Obesity and Type 2 Diabetes Mellitus: Evidence of Interaction With Appetite-Regulating, Metabolic and Inflammatory Factors.

Endocrinology, diabetes & metabolism·2025
Same author

GDF15 Is Elevated in Eating Disorders and Is Involved in the Gut-Brain Axis via Ghrelin.

European eating disorders review : the journal of the Eating Disorders Association·2025
Same journal

AKR1C3 inhibitors and exploiters for the treatment and therapeutic monitoring of cancer: a patent review 2020-present.

Expert opinion on therapeutic patents·2026
Same journal

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).

Expert opinion on therapeutic patents·2026
Same journal

Takeda G-protein-coupled receptor 5 and farnesoid X receptor agonists for diabetes treatment: a patent review and clinical advancements (2015-present).

Expert opinion on therapeutic patents·2026
Same journal

A patent review of GPR84 receptor antagonists (2020-present).

Expert opinion on therapeutic patents·2026
Same journal

SLIT2 and ROBO-axis inhibitors for the treatment of cancer: a patent review (2020-2026).

Expert opinion on therapeutic patents·2026
Same journal

New insights on anticancer glucocorticoid receptor modulators: a patent review (2020-present).

Expert opinion on therapeutic patents·2026
See all related articles

Related Experiment Video

Updated: Aug 7, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.2K

Malaria vaccines.

Michael Quagliata1, Anna Maria Papini1, Paolo Rovero2

  • 1Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff," University of Florence, Sesto Fiorentino, Italy.

Expert Opinion on Therapeutic Patents
|March 13, 2023
PubMed
Summary
This summary is machine-generated.

Malaria eradication is crucial, necessitating advanced vaccines. Analyzing the patent landscape reveals a need for multi-stage malaria vaccines beyond current pre-erythrocytic options for improved efficacy.

Keywords:
Antibodyantigenimmune responsemalariavaccine

More Related Videos

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.5K
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.2K

Related Experiment Videos

Last Updated: Aug 7, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.2K
Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
08:46

Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites

Published on: May 18, 2016

17.5K
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
10:38

High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays

Published on: July 17, 2014

23.2K

Area of Science:

  • Immunology
  • Vaccinology
  • Parasitology

Background:

  • Malaria eradication is a global health priority, with high mortality rates persisting despite treatment advances.
  • The recent approval of the first malaria vaccine highlights the importance of prevention, but its efficacy is limited.
  • The complex Plasmodium lifecycle necessitates diverse vaccine strategies targeting different parasite stages.

Purpose of the Study:

  • To analyze the patent landscape of malaria vaccines, focusing on significant patents published after 2016.
  • To classify malaria vaccine patents based on the targeted parasite stages and specific antigens or epitopes.
  • To identify trends and potential future directions in malaria vaccine development.

Main Methods:

  • Systematic search of 'malaria vaccine' in Patentscope and Espacenet databases.
  • Analysis of patents published post-2016.
  • Classification of patents by targeted malaria parasite stage (e.g., pre-erythrocytic, blood-stage) and specific antigens/epitopes.

Main Results:

  • The patent landscape shows continued innovation in malaria vaccine development, particularly for pre-erythrocytic stages.
  • There is a growing interest in multi-antigen vaccines targeting various parasite stages for enhanced efficacy.
  • Emerging technologies aim to improve vaccine stability and delivery in resource-limited settings.

Conclusions:

  • While pre-erythrocytic vaccines like RTS,S show promise, broader stage-specific targeting is needed.
  • Multi-antigenic and multi-stage vaccines represent a promising strategy for more effective malaria prevention.
  • Technological advancements in vaccine formulation and storage are critical for global malaria control efforts.